Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vibrio cholerae killed whole cells are the primary antigenic components of inactivated oral cholera vaccines (OCVs), such as Dukoral, Shanchol, and Euvichol [WHO, 2017]. These cells are prepared by inactivating various strains of Vibrio cholerae, typically including the O1 serogroup (Inaba and Ogawa biotypes) and sometimes the O139 serogroup, using heat or chemicals like formalin [Clemens et al., 2017]. Although not a single molecular target like a receptor or enzyme, these killed cells function as a complex immunogen that stimulates the gut-associated lymphoid tissue (GALT) [Lopez et al., 2014]. The primary biological response is the induction of mucosal immunity through the production of secretory IgA (sIgA) and systemic vibriocidal antibodies, which prevent the live pathogen from colonizing the small intestine [Wierzba et al., 2015]. This mechanism effectively neutralizes the bacteria before they can produce the cholera toxin responsible for the severe secretory diarrhea characteristic of the disease [Bhattacharya et al., 2013]. These killed whole-cell preparations are crucial for public health interventions in cholera-endemic regions and during humanitarian crises to prevent large-scale outbreaks [CDC, 2022].
Induction of mucosal and systemic immunity through the production of secretory IgA and vibriocidal antibodies against bacterial surface antigens [Clemens et al., 2017].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vibrio cholerae killed whole cells (WC-OCV).